Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
Publication date: Available online 4 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ling Yu, Zhenjie Wang, Zhuomao Mo, Binhua Zou, Yuanyuan Yang, Rui Sun, Wen Ma, Meng Yu, Shijun Zhang, Zhiqiang Yu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 4, 2021 Category: Cancer & Oncology Source Type: research
Cell membrane-derived vesicles for delivery of therapeutic agents
Publication date: Available online 1 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Quoc-Viet Le, Jaiwoo Lee, Hobin Lee, Gayong Shim, Yu-Kyoung Oh (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 2, 2021 Category: Cancer & Oncology Source Type: research
Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between “seed and soil”
Publication date: Available online 2 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Junyu Wu, Yang Long, Man Li, Qin He (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 2, 2021 Category: Cancer & Oncology Source Type: research
The chromosome-level reference genome assembly for Dendrobium officinale and its utility of functional genomics research and molecular breeding study
Publication date: Available online 2 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhitao Niu, Fei Zhu, Yajuan Fan, Chao Li, Benhou Zhang, Shuying Zhu, Zhenyu Hou, Mengting Wang, Jiapeng Yang, Qingyun Xue, Wei Liu, Xiaoyu Ding (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 2, 2021 Category: Cancer & Oncology Source Type: research
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
Publication date: Available online 2 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Guoyi Tang, Sha Li, Cheng Zhang, Haiyong Chen, Ning Wang, Yibin Feng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 2, 2021 Category: Cancer & Oncology Source Type: research
AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
Publication date: Available online 26 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Qingqing Dai, Yuhang Yan, Xiangli Ning, Gen Li, Junlin Yu, Ji Deng, Lingling Yang, Guo-Bo Li (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 26, 2021 Category: Cancer & Oncology Source Type: research
Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson’s disease treatment
Publication date: Available online 26 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Junmei Shang, Shurong Ma, Caixia Zang, Xiuqi Bao, Yan Wang, Dan Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 26, 2021 Category: Cancer & Oncology Source Type: research
Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder
Publication date: Available online 24 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Lulu Pang, Siqing Zhu, Jinqiu Ma, Lin Zhu, Yijing Liu, Ge Ou, Ruiteng Li, Yaxin Wang, Yi Liang, Xu Jin, Lina Du, Yiguang Jin (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
Publication date: Available online 24 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yanan Li, Cangang Zhang, Guo Li, Guowei Deng, Hui Zhang, Yongbing Sun, Feifei An (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
Tumor microenvironments self-activated nanoscale metal organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy
Publication date: Available online 23 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yu Liang, Li Zhang, Chao Peng, Shiyu Zhang, Siwen Chen, Xin Qian, Wanxian Luo, Qing Dan, Yongyan Ren, Yingjia Li, Bingxia Zhao (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats
Publication date: Available online 23 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Chenchen Han, Yifan Li, Yuwen Zhang, Yang Wang, Dongqian Cui, Tingting Luo, Yu Zhang, Qian Liu, Hao Li, Chun Wang, Dexiang Xu, Yang Ma, Wei Wei (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers
Publication date: Available online 24 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Edgar Pérez-Herrero, Alberto Fernández-Medarde (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
Publication date: Available online 24 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Lin Hou, Yanlong Liu, Wei Liu, Mervat Balash, Hongling Zhang, Yi Zhang, Huijuan Zhang, Zhenzhong Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 25, 2021 Category: Cancer & Oncology Source Type: research
Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer
Publication date: Available online 21 January 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yi Qian, Meimei Zhao, Qinghua Han, Jingkang Wang, Lixi Liao, Heng Yang, Dan Liu, Pengfei Tu, Hong Liang, Kewu Zeng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 22, 2021 Category: Cancer & Oncology Source Type: research
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
Publication date: January 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 1Author(s): Bing Zhao, Xinhui Zhang, Tingting Yu, Ying Liu, Xiaoling Zhang, Yongfang Yao, Xuejian Feng, Hongmin Liu, Dequan Yu, Liying Ma, Shangshang Qin (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - January 21, 2021 Category: Cancer & Oncology Source Type: research
